Davidson Kempner Capital Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-450,000
| Closed | -$4.54M | – | 459 |
|
|
2022
Q4 | $4.54M | Hold |
450,000
| – | – | 0.09% | 175 |
|
|
2022
Q3 | $4.46M | Hold |
450,000
| – | – | 0.08% | 202 |
|
|
2022
Q2 | $4.42M | Hold |
450,000
| – | – | 0.08% | 216 |
|
|
2022
Q1 | $4.43M | Hold |
450,000
| – | – | 0.06% | 238 |
|
|
2021
Q4 | $4.42M | Hold |
450,000
| – | – | 0.07% | 229 |
|
|
2021
Q3 | $4.38M | Buy |
450,000
+57,202
| +15% | +$557K | 0.06% | 201 |
|
|
2021
Q2 | $3.79M | Buy |
+392,798
| New | +$3.79M | 0.03% | 271 |
|